Resistance management of molotinib/mometinib

Momelotinib is a selective inhibitor of JAK1 and JAK2 and is mainly used to treat certain types of bone marrow abnormalities and malignant diseases. However, as treatment progresses, patients may develop resistance to the drug. The mechanisms of drug resistance are usually complex and involve factors such as genetic variation of tumor cells, reprogramming of signaling pathways, and changes in the microenvironment.

A variety of strategies can be considered when dealing with the problem of molotinib resistance. First, genetic testing can help identify mutations associated with drug resistance, such as JAK2 V617F or changes in other key disease-causing genes. This information can guide doctors whether they need to adjust the treatment plan or introduce other targeted drugs. In addition, the efficacy may also be improved by combining drugs with different mechanisms, such as immune checkpoint inhibitors or other targeted therapies. In this way, the chance of tumor cells escaping the effects of the drug can be reduced, thereby overcoming drug resistance.

Another important management strategy is to optimize the treatment regimen, including adjusting the dosage, frequency or cycle of administration. In the early stages of the development of drug resistance, the progression of tumor cell resistance to molotinib may be slowed down by prolonging the medication interval or briefly discontinuing the drug. In addition, strict monitoring and evaluation of patients, including regular imaging examinations and biochemical index tests, can help to detect signs of drug resistance in a timely manner and intervene accordingly.

In drug resistance management, individualized treatment of patients is crucial. Each patient's tumor characteristics and biomarkers may be different, making it particularly important to develop a targeted treatment plan. At the same time, doctors also need to pay attention to the patient's general condition, comorbidities, and quality of life to comprehensively balance treatment effects and side effects.